Float Short %

6.47

Margin Of Safety %

-10

Put/Call OI Ratio

3.76

EPS Next Q Diff

EPS Last/This Y

2.14

EPS This/Next Y

0.49

Price

127.97

Target Price

184

Analyst Recom

1.55

Performance Q

-12.13

Relative Volume

0.59

Beta

1.15

Ticker: RGEN

23 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-04-14	RGEN	127.29	2.22	0.05	8443
2025-04-15	RGEN	126.59	2.32	3.89	8336
2025-04-16	RGEN	132.24	2.54	0.02	9776
2025-04-17	RGEN	130.12	2.12	0.77	10314
2025-04-18	RGEN	130	2.12	0.77	10314
2025-04-21	RGEN	131.67	5.09	0.42	8071
2025-04-22	RGEN	138.93	5.47	0.23	8572
2025-04-23	RGEN	141.4	5.45	2.25	8577
2025-04-24	RGEN	145.35	5.45	3.71	8595
2025-04-25	RGEN	144.75	5.4379671150972	0.20588235294118	8614
2025-04-28	RGEN	143.63	5.138125440451	3.9469387755102	8710
2025-04-29	RGEN	139.46	5.46	0.24	10498
2025-04-30	RGEN	137.96	4.03	0.12	11159
2025-05-01	RGEN	137.19	3.08	0.12	11894
2025-05-02	RGEN	141.72	3.07	2.78	11891
2025-05-05	RGEN	141.11	3.06	0.00	11891
2025-05-06	RGEN	130.28	3.20	0.33	11763
2025-05-07	RGEN	126.74	3.20	0.67	11771
2025-05-08	RGEN	127.86	3.20	0.01	11768
2025-05-09	RGEN	123.1	3.81	2.50	11317
2025-05-12	RGEN	133.74	3.81	0.58	11347
2025-05-13	RGEN	131.52	3.80	0.12	11358
2025-05-14	RGEN	127.97	3.76	0.44	11321
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-04-14	RGEN	127.26	25.2	73.1	1.71
2025-04-15	RGEN	126.62	25.2	70.4	1.71
2025-04-16	RGEN	132.25	25.2	73.6	1.71
2025-04-17	RGEN	130.00	25.2	69.7	1.71
2025-04-18	RGEN	130.00	25.2	70.7	1.71
2025-04-21	RGEN	131.68	25.0	71.6	1.71
2025-04-22	RGEN	138.93	25.0	74.3	1.71
2025-04-23	RGEN	141.40	25.0	71.9	1.71
2025-04-24	RGEN	145.25	25.0	72.5	1.71
2025-04-25	RGEN	144.75	25.0	70.5	1.71
2025-04-28	RGEN	143.63	25.0	70.2	1.71
2025-04-29	RGEN	139.43	25.0	68.8	1.71
2025-04-30	RGEN	137.99	25.6	70.1	1.70
2025-05-01	RGEN	137.20	25.6	66.6	1.70
2025-05-02	RGEN	141.51	17.2	69.0	1.68
2025-05-05	RGEN	140.92	17.2	66.7	1.68
2025-05-06	RGEN	130.35	17.2	61.4	1.68
2025-05-07	RGEN	126.88	17.2	64.5	1.68
2025-05-08	RGEN	127.86	17.2	66.8	1.68
2025-05-09	RGEN	123.22	17.2	63.9	1.68
2025-05-12	RGEN	133.72	17.2	71.8	1.68
2025-05-13	RGEN	131.55	17.2	65.2	1.68
2025-05-14	RGEN	127.97	17.2	64.5	1.68
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

23 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-04-14	RGEN	-1.60	1.41	6.68
2025-04-15	RGEN	-1.60	1.41	6.68
2025-04-16	RGEN	-1.60	1.41	6.68
2025-04-17	RGEN	-1.60	1.41	6.68
2025-04-18	RGEN	-1.60	1.41	6.68
2025-04-21	RGEN	-1.60	1.38	6.68
2025-04-22	RGEN	-1.60	1.38	6.68
2025-04-23	RGEN	-1.60	1.38	6.68
2025-04-24	RGEN	-1.60	1.38	6.68
2025-04-25	RGEN	-1.60	1.38	6.68
2025-04-28	RGEN	-1.60	1.53	6.12
2025-04-29	RGEN	-1.60	1.53	6.12
2025-04-30	RGEN	-1.60	1.53	6.12
2025-05-01	RGEN	-1.60	1.53	6.12
2025-05-02	RGEN	-1.60	1.53	6.12
2025-05-05	RGEN	-1.60	-1.45	6.11
2025-05-06	RGEN	-1.62	-1.45	6.11
2025-05-07	RGEN	-1.62	-1.45	6.11
2025-05-08	RGEN	-1.62	-1.45	6.10
2025-05-09	RGEN	-1.62	-1.45	6.10
2025-05-12	RGEN	-1.62	1.41	6.47
2025-05-13	RGEN	-1.62	1.41	6.47
2025-05-14	RGEN	-1.62	1.41	6.47
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

23 items 1 of 1

Last Quarter Act. EPS

0.39

Avg. EPS Est. Current Quarter

0.39

Avg. EPS Est. Next Quarter

0.39

Insider Transactions

-1.62

Institutional Transactions

1.41

Beta

1.15

Average Sales Estimate Current Quarter

174

Average Sales Estimate Next Quarter

174

Fair Value

114.92

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

60.9

Max Drawdown 5-Year %

-66.4

Target Price

184

P/E

Forward P/E

58.87

PEG

P/S

11.06

P/B

3.62

P/Free Cash Flow

60.08

EPS

-0.41

Average EPS Est. Cur. Y

1.68

EPS Next Y. (Est.)

2.17

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-3.53

Relative Volume

0.59

Return on Equity vs Sector %

-24.8

Return on Equity vs Industry %

-9.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.03

EBIT Estimation

64.5

Repligen Corporation

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 1778

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

stock quote shares RGEN – Repligen Corporation Stock Price stock today

news today RGEN – Repligen Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch RGEN – Repligen Corporation yahoo finance google finance

stock history RGEN – Repligen Corporation invest stock market

stock prices RGEN premarket after hours

ticker RGEN fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: RGEN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y